Package insert. Manoplax (flosequinan). Lincolnshire, IL: Boots Pharmaceuticals, December 1992.
2.
PittB. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure (abstract). Circulation1991; 84: (suppl II):311.
3.
PackerMNaraharaKAElkavamUSullivanJMPearleDLMassieBMRandomized, multicenter, double-blind, placebo-controlled study of the efficacy of flosequinan, a new, long-acting vasodilator drug in patients with chronic heart failure (abstract). Circulation1990; 82 (suppl III):323.
4.
BashirYO'NunainSPaulVEButrousGSWardDECammAJ. The electrophysiological effects of flosequinan. Eur Heart J1991; 12: 1288–92.
5.
YatesDB. Pharmacology of flosequinan. Am Heart J1991; 121: 974–83.
6.
NaccarelliGVGoldsteinRA. Electrophysiology of phosphodiesterase inhibitors. Am J Cardiol1989; 63 (suppl):35A–40A.
7.
MarsHKrallJ. L-dopa and cardiac arrhythmias. N Engl J Med1971; 285: 1437–9.
8.
MillerJL. Reviews of new drugs (editorial). Clin Pharm1993; 12: 306.
